$0.284800
-0.0058-2.00%
At Close: -
$0.281500
-0.0033-1.16%
After Hours: 5:07 PM EDT
15 minutes delayed
Renalytix reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Renalytix using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-15 | $-0.08 | $-0.07 | -14.3 % |
Dec 2023 | 2024-02-14 | $-0.09 | $-0.09 | 0.00 % |
Sep 2023 | 2023-11-14 | $-0.11 | $-0.10 | -10.0 % |
Jun 2023 | 2023-09-28 | $-0.11 | $-0.13 | 15.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-15 | $535.00K | $950.00K | -43.7 % |
Dec 2023 | 2024-02-14 | $709.00K | $750.00K | -5.47 % |
Sep 2023 | 2023-11-14 | $459.00K | $700.00K | -34.4 % |
Jun 2023 | 2023-09-28 | $518.00K | $720.00K | -28.1 % |
Renalytix (RNLX) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on May 15, 2024 for Q3.
The Actual EPS was $-0.08, which missed the estimate of $-0.07.
The Actual Revenue was $535K, which missed the estimate of $950K.
Browse earnings estimates, EPS, and revenue on all stocks.